Enter your username/e-mail and your new password will be send to you.
| Title | European Clinical Research Infrastructures Network - Integrating Activity |
| Grant Agreement Number | 284395 |
| Funding Programmes | FP7 |
| Dates | 01/01/2012 - 31/12/2015 |
| Project URL | http://www.inserm.fr/index.php |
| Scientific Domain |
Biological and Medical Sciences |
| Action Line | Combination of CP & CSA |
| Type Of Project | CP-CSA-INFRA |
| Abstract | ECRIN is a distributed ESFRI-roadmap pan-European infrastructure designed to support multinational clinical research, making Europe a single area for clinical studies, taking advantage of its population size to access patients. Servicing multinational trials started during its preparatory phase, and it now applies for an ERIC status by 2011. The ERIC budget will be restricted to core activities required to enable provision of services, and the ECRIN-IA project is designed to expand ECRIN partnerships and impact beyond this core activity. Networking activities will promote pan-European expansion, capacity building, and partnership with other world regions, and address the funding issue (WP2). ECRIN-IA will develop e-services, education material to train professionals and patients associations, and communication with users, patients, citizens and policymakers (WP3). It will support the structuring and connection to ECRIN of disease-, technology-, or product-oriented investigation networks and hubs focusing on specific areas: rare diseases (WP4), medical device (WP5), nutrition (WP6). Transnational access activities will support the cost of multinational extension of clinical trials on rare diseases, medical device and nutrition selected by the ECRIN scientific board (WP7). Joint research activities are designed to improve the efficiency of ECRIN services, through the development of tools for risk-adapted monitoring (WP8), and the upgrade of the VISTA data management tool (WP9). This project will build a consistent organisation for clinical research in Europe, with ECRIN developing generic tools and providing generic services to multinational studies, and supporting the construction of pan-European disease-oriented networks, that will in turn act as ECRIN users and provide the scientific content. Such organisation will improve Europe’s attractiveness for industry trials, boost its scientific competitiveness, and result in better healthcare for European citizens. |
|
Partners
(Organisation name and Country) |
DOKUZ EYLUL UNIVERSITESI, Turkey KAROLINSKA INSTITUTET, Sweden Masarykova univerzita, Czech Republic UNIVERSITY OF LEEDS, United Kingdom ISTITUTO SUPERIORE DI SANITA, Italy MEDIZINISCHE UNIVERSITAET WIEN, Austria WARSZAWSKI UNIWERSYTET MEDYCZNY, Poland Finn-Medi Oy, Finland MOLECULAR MEDICINE IRELAND LBG, Ireland EGESZSEGUGY MINISZTERIUMI, Hungary ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI, Italy REGION HOVEDSTADEN, Denmark CONSORZIO ITALIANO PER LA RICERCA MEDICA, Italy HEINRICH-HEINE-UNIVERSITAET DUESSELDORF, Germany UNIVERSITAIR MEDISCH CENTRUM UTRECHT, Netherlands LANDSPITALI UNIVERSITY HOSPITAL, Iceland KLINIKUM DER UNIVERSITAET ZU KOELN, Germany CENTRE DE RECHERCHE PUBLIC DE LA SANTE, Luxembourg CONSORCIO DE APOYO A LA INVESTIGACION BIOMEDICA EN RED, Spain VERENIGING SAMENWERKENDE OUDER- EN PATIENTENORGANISATIES, Netherlands QUALISSIMA, France UNIVERSITATEA DE MEDICINA SI FARMACIE DIN CRAIOVA, Romania ST OLAVS HOSPITAL HF, Norway EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION, France UNITRANSFERKLINIK LUBECK GMBH, Germany SWISS CLINICAL TRIAL ORGANISATION VEREIN, Switzerland SRPSKO LEKARSKO DRUSTVO, Serbia EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL, Belgium TEL AVIV UNIVERSITY, Israel FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA, Spain UNIVERSIDADE NOVA DE LISBOA (INSTITUTO DE TECNOLOGIA QUIMICA E BIOLOGICA), Portugal UNIVERSIDADE NOVA DE LISBOA, Portugal AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM, Portugal ESPEN-LA SOCIETE EUROPEENNE DE NUTRITION CLINIQUE ET METABOLISME ASBL, Luxembourg FACULDADE DE CIENCIAS MEDICAS DA UNIVERSIDADE NOVA DE LISBOA, Portugal |
